Metraipolis › archive › dc_ccd2e9785c26

Correction of VWF multimerization in type 2A/IIC von Willebrand disease by exogenous VWF propeptide supplementation — Europe PMC PMID:40958414

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40958414
DOI
10.1016/j.ymthe.2025.09.027
License (as archived)
solo-consultazione
Archived
2026-11-09T22:07:45.575Z
SHA-256 of the archived text
73526d6e6831ca5b1189b95798c71eb041a8e65c4aa565af99693b8f78042302
Stable URL of this page
https://metraipolis.com/documento/dc_ccd2e9785c26

How to cite

Correction of VWF multimerization in type 2A/IIC von Willebrand disease by exogenous VWF propeptide supplementation — Europe PMC PMID:40958414 — Europe PMC (en), https://europepmc.org/article/MED/40958414 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccd2e9785c26 (Metraipolis archive dc_ccd2e9785c26, sha256 73526d6e6831ca5b1189b95798c71eb041a8e65c4aa565af99693b8f78042302)
BibTeX
@misc{dcccd2e9785c26,
  title = {Correction of VWF multimerization in type 2A/IIC von Willebrand disease by exogenous VWF propeptide supplementation — Europe PMC PMID:40958414},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40958414},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccd2e9785c26; sha256 73526d6e6831ca5b1189b95798c71eb041a8e65c4aa565af99693b8f78042302},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40958414. Agents can read the archived copy with the MCP tool read_document.